Search Our Clinical Trials

Conducting trials on a wide range of cancer treatments

The Oncology Institute of Hope and Innovation is a leader in clinical studies, with the goal to advance the treatment of cancer. We conduct more trials than most other community cancer groups in the US. Our research helps us evaluate the effectiveness of treatment, reduce the risk of complications, lower costs and save resources, and continually refine our clinical approach to cancer care.

Abbvie M16-109

A Phase 2 Open-Label Study Evaluating Tolerability and Efficacy of Navitoclax Alone or in Combination with Ruxolitinib in Subjects with Myelofibrosis

Locations

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

1701 E. Cesar Chavez Ave.
Suite 535
Los Angeles, CA 90033

3628 E. Imperial Hwy.
Suite 401
Lynwood, CA 90262

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Myelofibrosis
Request Information
Acerta Pharma ACE-LY-003 (Part 2)

An Open-Label, Phase 1b/2 Study of Acalabrutinib Alone or in Combination Therapy in Subjects with B-cell Non-Hodgkin Lymphoma

Locations

1801 W Romneya Dr.
Suite 103
Anaheim, CA 92801

11480 Brookshire Ave.
Suite 309
Downey, CA 90241

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

3628 E. Imperial Hwy.
Suite 401
Lynwood, CA 90262

101 E. Beverly Blvd.
Suite 200
Montebello, CA 90640

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Indolent Non-Hodgkins Lymphoma
Request Information
ADC Therapeutics ADCT-402-311

A Phase 3 Randomized Study of Loncastuximab Tesirine Combined with Rituximab Versus Immunochemotherapy in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

Locations

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

3628 E. Imperial Hwy.
Suite 401
Lynwood, CA 90262

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Non-Hodgkins Lymphoma (DLBCL)
Request Information
An Heart / AB-106-G208

A Single-Arm, Open-Label, Multicenter Phase 2 Study to Evaluate the Efficacy and Safety of Taletrectinib in Patients with Advanced or Metastatic ROS1 Positive NSCLC and Other Solid Tumors.

Locations

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Lung Cancer (NSCLC) Solid Tumors
Request Information
Arcus Biosciences ARC-6

A Phase 1b/2, Open-Label, Randomized Platform Study Evaluating the Efficacy and Safety of AB928-Based Treatment Combinations in Patients with Metastatic Castrate Resistant Prostate Cancer

Locations

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Prostate Cancer
Request Information
Arcus Biosciences AB154CSP0002 (ARC-7)

A Phase 2 Study to Evaluate the Safety and Efficacy of AB122 Monotherapy, AB154 in Combination with AB122, and AB154 in Combination with AB122 and AB928 in Front-Line, Non-Small Cell Lung Cancer

Locations

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

3628 E. Imperial Hwy.
Suite 401
Lynwood, CA 90262

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Lung Cancer - NSCLC
Request Information
Astellas 8951-CL-5201

A Phase 2, Open-Label, Randomized Study to Assess the Antitumor Activity and Safety of Zolbetuximab (IMAB362) in Combination with Nab-Paclitaxel and Gemcitabine (Nab-P + GEM) as First-Line Treatment in Subjects with Claudin 18.2 (CLDN18.2) Positive, Metastatic Pancreatic Adenocarcinoma

Locations

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Pancreatic Cancer
Request Information
Astrazeneca D3614C00001 (CAPItello-290)

A Phase III Double-Blind Randomized Study Assessing the Efficacy and Safety of Capivasertib + Paclitaxel Versus Placebo + Paclitaxel as First-line Treatment for Patients with Histologically Confirmed, Locally Advanced (Inoperable) or Metastatic Triple-Negative Breast Cancer (TNBC) (CAPItello-290)

Locations

900 S. Main St.
Suite 204
Corona, CA 92882

11480 Brookshire Ave.
Suite 309
Downey, CA 90241

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

3628 E. Imperial Hwy.
Suite 401
Lynwood, CA 90262

101 E. Beverly Blvd.
Suite 200
Montebello, CA 90640

4500 Brockton Ave.
Suite 316
Riverside, CA 92501

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

1250 S. Sunset Ave.
Suite 101
West Covina, CA 91790

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Breast Cancer
Request Information
Astrazeneca D4194C00008

Prospective, Interventional Pilot Study of Mobile Devices and Digital Applications to Detect Early Pneumonitis and Other Pulmonary Adverse Events in Unresectable Stage III Non-Small Cell Lung Cancer Patients on Durvalumab

Locations

900 S. Main St.
Suite 204
Corona, CA 92882

11480 Brookshire Ave.
Suite 309
Downey, CA 90241

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

4500 Brockton Ave.
Suite 316
Riverside, CA 92501

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Lung Cancer - NSCLC
Request Information
BioNTech RNA Pharmaceuticals, BNT122-01

A multi-site, open-label, Phase II, randomized, controlled trial to compare the efficacy of RO7198457 versus watchful waiting in resected, Stage II (high risk) and Stage III colorectal cancer patients who are ctDNA positive following resection

Locations

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Colorectal Cancer
Request Information
Bluestar Genomics IPROCESS-BSG-001-US

Collection and Distribution of Biofluids and Tumor Tissue Biospecimens for Research Purposes

Locations

900 S. Main St.
Suite 204
Corona, CA 92882

11480 Brookshire Ave.
Suite 309
Downey, CA 90241

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

1701 E. Cesar Chavez Ave.
Suite 535
Los Angeles, CA 90033

3628 E. Imperial Hwy.
Suite 401
Lynwood, CA 90262

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

1250 S. Sunset Ave.
Suite 101
West Covina, CA 91790

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Solid Tumors (Multiple)
Request Information
Blue Note Therapeutics, PROT001

Double-Blinded, Randomized, Controlled, Adaptive Trial To Compare Effectiveness Of Two Digital Software Medical Devices (Attunetm And Cerenatm) As Interventions For Physical And Emotional Health In Adjunctive Oncology Treatment, In Order To Determine Relative Impact On Anxiety And Depressive Symptoms In Stage I-III Breast Cancer And Stage I-III Non-Small Cell Lung Cancer Participants.

Locations

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

1707 W. St Marys Rd.
Suite 275
Tucson, AZ 85745

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Breast Cancer Lung Cancer (NSCLC)
Request Information
BMS CA2097A8

Randomized, Non-Comparative Neoadjuvant Phase II Study in Patients with ER+/HER2- Breast Cancer delete ? 2 cm with Safety Run-In, Assessing Nivolumab + Palbociclib + Anastrozole (CheckMate 7A8: CHECKpoint Pathway and NivoluMAb Clinical Trial Evaluation 7A8)

Locations

11480 Brookshire Ave.
Suite 309
Downey, CA 90241

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Breast Cancer
Request Information
BMS CA2097FL (CheckMate 7FL)

A Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 3 Study of Nivolumab Versus Placebo in Combination with Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy in Patients with High-Risk, Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Primary Breast Cancer

Locations

11480 Brookshire Ave.
Suite 309
Downey, CA 90241

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Breast Cancer
Request Information
Celgene ACE-536-MDS-002 (COMMANDS)

A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY TO COMPARE THE EFFICACY AND SAFETY OF LUSPATERCEPT (ACE-536) VERSUS EPOETIN ALFA FOR THE TREATMENT OF ANEMIA DUE TO IPSS-R VERY LOW, LOW OR INTERMEDIATE RISK MYELODYSPLASTIC SYNDROMES (MDS) IN ESA NAÏVE SUBJECTS WHO REQUIRE RED BLOOD CELL TRANSFUSIONS

Locations

1801 W Romneya Dr.
Suite 103
Anaheim, CA 92801

900 S. Main St.
Suite 204
Corona, CA 92882

11480 Brookshire Ave.
Suite 309
Downey, CA 90241

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

1701 E. Cesar Chavez Ave.
Suite 535
Los Angeles, CA 90033

3628 E. Imperial Hwy.
Suite 401
Lynwood, CA 90262

101 E. Beverly Blvd.
Suite 200
Montebello, CA 90640

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

21605 Hawthorne Blvd.
Suite 200
Torrance, CA 90503

1250 S. Sunset Ave.
Suite 101
West Covina, CA 91790

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted MDS (anemia in MDS patients)
Request Information
Celsion 201-17-201

A Phase I/II Study Evaluating the Dosing, Safety, Efficacy, and Biological Activity of Intraperitoneal GEN-1 (IL-12 Plasmid Formulated with PEG-PEI-Cholesterol Lipopolymer) Administered in Combination with Neoadjuvant Chemotherapy (NACT) in Patients Newly Diagnosed with Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Locations

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Ovarian, Fallopian or 1ry Peritoneal
Request Information
Daiichi Sankyo DS1062-A-U301

Phase 3 Randomized Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer without Actionable Genomic Alterations (TROPION-Lung01)

Locations

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Lung Cancer (NSCLC)
Request Information
DAIICHI SANKYO DS8201-A-U301

A Phase 3, Multicenter, Randomized, Open-Label, Active-Controlled Study of Trastuzumab Deruxtecan (DS-8201A), an Anti-HER2-Antibody Drug Conjugate, Versus Treatment of Investigator’s Choice for HER2-Positive, Unresectable and/or Metastatic Breast Cancer Subjects Previously Treated with T-DM1

Locations

3300 E. South St.
Suite 304
Long Beach, CA 90805

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Breast Cancer
Request Information
Daiichi Sankyo, PL3397-A-U401

A long-term study to further evaluate the risk of hepatotoxicity associated with TURALIO™ (pexidartinib) treatment.

Locations

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Observational
Request Information
Dr. Reddy’s Laboratories RI-01-006

A Randomized, Double-Blind, Parallel-Group, Phase III Study to Compare the Efficacy, Safety, and Immunogenicity of Proposed Rituximab Biosimilar (DRL_RI) with MabThera® in Subjects with Previously Untreated, Stage II-IV, Cluster of Differentiation (CD)20-Positive, Low Tumour Burden Follicular Lymphoma

Locations
Cancer Targeted Follicular Lymphoma
Request Information
eFFECTOR Therapeutics, eFT508-0011

A Randomized, Double-Blind, Placebo-Controlled Trial of Tomivosertib in Combination With Anti-PD-(L)1 Therapy in Subjects With Non-Small Cell Lung Cancer as First-Line Therapy or When Progressing on Single-Agent First-Line Anti-PD-(L)1 Therapy

Locations

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Lung Cancer (NSCLC)
Request Information
Eleison EP-GF-301

A Randomized Phase 3 Study of the Efficacy and Safety of Glufosfamide Compared with Fluorouracil (5-FU) in Patients with Metastatic Pancreatic Adenocarcinoma Previously Treated with Gemcitabine

Locations

1801 W Romneya Dr.
Suite 103
Anaheim, CA 92801

11480 Brookshire Ave.
Suite 309
Downey, CA 90241

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

3628 E. Imperial Hwy.
Suite 401
Lynwood, CA 90262

101 E. Beverly Blvd.
Suite 200
Montebello, CA 90640

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Pancreatic Cancer
Request Information
EMD Serono MS200095-0031

A Phase II, two-arm study to investigate tepotinib combined with osimertinib in MET amplified, advanced or metastatic non-small cell lung cancer (NSCLC) harboring activating EGFR mutations and having acquired resistance to prior osimertinib therapy (INSIGHT 2 Study)

Locations

1513 S. Grand Ave.
Suite 360
Los Angeles, CA 90015

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

3628 E. Imperial Hwy.
Suite 401
Lynwood, CA 90262

101 E. Beverly Blvd.
Suite 200
Montebello, CA 90640

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Lung Cancer (NSCLC)
Request Information
Epizyme EZH-302

A Phase 1B/3 Double-Blind, Randomized, Active-Controlled, 3-Stage, Biomarker Adaptive Study of Tazemetostat or Placebo In Combination with Lenalidomide plus Rituximab in Subjects with Relapsed/Refractory Follicular Lymphoma

Locations

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Follicular Lymphoma
Request Information
G1 Therapeutics, G1T28-207: PRESERVE 1

A Phase 3 Randomized, Double-blind Trial of Trilaciclib versus Placebo in Patients Receiving FOLFOXIRI/Bevacizumab for Metastatic Colorectal Cancer

Locations

1801 W Romneya Dr.
Suite 103
Anaheim, CA 92801

900 S. Main St.
Suite 204
Corona, CA 92882

11480 Brookshire Ave.
Suite 309
Downey, CA 90241

1513 S. Grand Ave.
Suite 360
Los Angeles, CA 90015

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

3628 E. Imperial Hwy.
Suite 401
Lynwood, CA 90262

101 E. Beverly Blvd.
Suite 200
Montebello, CA 90640

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

1250 S. Sunset Ave.
Suite 101
West Covina, CA 91790

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Colorectal Cancer
Request Information
G1 Therapeutics, (G1T28-209)

A Phase 2, Randomized, Open-Label Study of Trilaciclib Administered with First-Line Platinum-Based Chemotherapy and Avelumab Maintenance Therapy in Patients with Untreated, Locally Advanced or Metastatic Urothelial Carcinoma (PRESERVE 3)

Locations

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Urothelial malignancy
Request Information
GSK / 213409

An Open-Label, Multicenter, Long-Term Treatment Extension Study In Subjects Who Have Completed A Prior Glaxosmithkline/Tesaro- Sponsored Niraparib Study And Are Judged By The Investigator To Benefit From Continued Treatment With Niraparib.

Locations

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Lung Cancer (NSCLC)
Request Information
GSK 213410

A randomized, open label phase 2/3 study. Efficacy Comparison of Cobolimab + Dostarlimab + Docetaxel to Dostarlimab + Docetaxel to Docetaxel Alone in Participants with Advanced Non small Cell Lung Cancer Who Have Progressed on Prior Anti PD (L)1 Therapy and Chemotherapy (COSTAR Lung)

Locations

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Lung Cancer (NSCLC)
Request Information
Helsinn ANAM-17-20

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Anamorelin HCL for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)

Locations

900 S. Main St.
Suite 204
Corona, CA 92882

1701 E. Cesar Chavez Ave.
Suite 535
Los Angeles, CA 90033

4500 Brockton Ave.
Suite 316
Riverside, CA 92501

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Lung Cancer - NSCLC
Request Information
Incyte Corporation, INCMOR0208-301

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Tafasitamab Plus Lenalidomide in Addition to Rituximab Versus Lenalidomide in Addition to Rituximab in Patients With Relapsed/Refractory(R/R) Follicular Lymphoma Grade 1 to 3a or R/R Marginal Zone Lymphoma

Locations

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

50 Bellefontaine St.
Suite 401
Pasadena, CA 91105

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Diffues Large B-Cell Lymphoma (DLBCL)/SLL/Marginal Zone Lymphoma/Follicular
Request Information
Incyte INCMGA 0012-304 (POD1UM304)

A Randomized, Double-Blind, Phase 3 Study of Platinum-Based Chemotherapy with or without INCMGA00012 in First-Line Metastatic Squamous and Nonsquamous Non-Small Cell Lung Cancer (POD1UM-304)

Locations

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

1701 E. Cesar Chavez Ave.
Suite 535
Los Angeles, CA 90033

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Lung Cancer - NSCLC
Request Information
Incyte INCMOR0208-301

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Tafasitamab Plus Lenalidomide in Addition to Rituximab Versus Lenalidomide in Addition to Rituximab in Patients With Relapsed/Refractory(R/R) Follicular Lymphoma Grade 1 to 3a or R/R Marginal Zone Lymphoma

Locations

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

50 Bellefontaine St.
Suite 401
Pasadena, CA 91105

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL)
Request Information
Janssen 54767414MMY2065

A Phase 2 Study of Daratumumab Subcutaneous (Dara-SC) Administration in Combination with Carfilzomib and Dexamethasone (DKd) Compared with Carfilzomib and Dexamethasone (Kd) in Participants with Multiple Myeloma who have been Previously Treated with Daratumumab Intravenous (Dara-IV) to Evaluate Daratumumab Retreatment

Locations

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Multiple Myeloma
Request Information
Jiangsu Hengrui HR-BLTN-III-NSCLC

A Phase 3, Randomized, Open-label, Multicenter Study of the Efficacy and Safety of Pyrotinib versus Docetaxel in Patients with Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC) Harboring a HER2 Exon 20 Mutation who Progressed on or after Treatment with Platinum Based Chemotherapy

Locations

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

1701 E. Cesar Chavez Ave.
Suite 535
Los Angeles, CA 90033

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Lung Cancer - NSCLC
Request Information
Kartos KRT-232-101

An Open-Label, Phase 2a/2b Study of KRT-232 in Subjects With Primary Myelofibrosis (PMF), Post–Polycythemia Vera MF (Post-PV-MF), Or Post–Essential Thrombocythemia MF (Post–ET-MF) Who Have Failed Prior Treatment with a JAK Inhibitor

Locations

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Myelofibrosis
Request Information
Kartos, 232-113

An Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of KRT-232 with TL-895 in Subjects with Relapsed/Refractory Myelofibrosis and of KRT-232 in Janus-associated Kinase Inhibitor Intolerant Myelofibrosis

Locations

900 S. Main St.
Suite 204
Corona, CA 92882

1513 S. Grand Ave.
Suite 360
Los Angeles, CA 90015

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Myelofibrosis
Request Information
Kartos KRT-232-114

An Open-Label, Multicenter, Phase 2 Study Assessing the Safety and Efficacy of KRT-232 or TL-895 in Janus associated Kinase

Locations

900 S. Main St.
Suite 204
Corona, CA 92882

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

4646 Brockton Ave.
Suite 203
Riverside, CA 92506

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Myelofibrosis
Request Information
Karyopharm Therapeutics KCP-330-024

A Randomized, Double-Blind, Phase 3 Trial Of Maintenance With Selinexor/ Placebo After Combination Chemotherapy For Patients With Advanced Or Recurrent Endometrial Cancer.

Locations

900 S. Main St.
Suite 204
Corona, CA 92882

11480 Brookshire Ave.
Suite 309
Downey, CA 90241

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

4500 Brockton Ave.
Suite 316
Riverside, CA 92501

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Endometrial
Request Information
Karyopharm XPORT-DLBCL-030

A Phase 2/3, Multicenter Randomized Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) with or without Selinexor in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (RR DLBCL)

Locations

11480 Brookshire Ave.
Suite 309
Downey, CA 90241

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Non-Hodgkins Lymphoma (DLBCL)
Request Information
Karyopharm, XPORT-MF-034

A Phase 1 / 2 Study to Evaluate Safety and Efficacy of Selinexor, a Selective Inhibitor of Nuclear Export, in Combination with Ruxolitinib in Treatment Naive Patients with Myelofibrosis

Locations

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

50 Bellefontaine St.
Suite 401
Pasadena, CA 91105

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Myelofibrosis
Request Information
Karyopharm, XPORT-MF-035

A Phase 2, Randomized, Open-Label, Multicenter Study to Evaluate Safety and Efficacy of Single Agent Selinexor versus Treatment of Physician’s Choice in Patients with Previously Treated Myelofibrosis.

Locations

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

50 Bellefontaine St.
Suite 401
Pasadena, CA 91105

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Myelofibrosis
Request Information
Kura KO-TIP-007

The AIM-HN and SEQ-HN Study: A 2 Cohort, Non-comparative, Pivotal Study Evaluating the Efficacy of Tipifarnib in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC) with HRAS Mutations (AIM-HN) and the Impact of HRAS Mutations on Response to First Line Systemic Therapies for HNSCC (SEQ-HN).

Locations

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Head and Neck cancer
Request Information
Lutris Pharma. Ltd., L-02-01

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Topically Administered LUT014 in Metastatic Colorectal Cancer Patients with EGFR Inhibitor Induced Acneiform Lesions.

Locations

900 S. Main St.
Suite 204
Corona, CA 92882

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

4646 Brockton Ave.
Suite 203
Riverside, CA 92506

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Colorectal Cancer
Request Information
Menarini Ricerche MEN1611-02

Open-Label, Multicenter, Phase IB/II Study of MEN1611, a PI3K Inhibitor, and Cetuximab in Patients with PIK3CA Mutated Metastatic Colorectal Cancer Failing Irinotecan, Oxaliplatin, 5-FU, and Anti-EGFR Containing Regimens

Locations

900 S. Main St.
Suite 204
Corona, CA 92882

11480 Brookshire Ave.
Suite 309
Downey, CA 90241

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

3628 E. Imperial Hwy.
Suite 401
Lynwood, CA 90262

101 E. Beverly Blvd.
Suite 200
Montebello, CA 90640

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Colorectal Cancer
Request Information
Mirati 516-005

A Randomized Phase 3 Study of Sitravatinib in Combination with Nivolumab Versus Docetaxel in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer with Disease Progression On or After Platinum-Based Chemotherapy and Checkpoint Inhibitor Therapy (SAPPHIRE)

Locations

1801 W Romneya Dr.
Suite 103
Anaheim, CA 92801

900 S. Main St.
Suite 204
Corona, CA 92882

11480 Brookshire Ave.
Suite 309
Downey, CA 90241

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

3628 E. Imperial Hwy.
Suite 401
Lynwood, CA 90262

101 E. Beverly Blvd.
Suite 200
Montebello, CA 90640

18433 Roscoe Blvd.
Suite 106
Northridge, CA 91325

4500 Brockton Ave.
Suite 316
Riverside, CA 92501

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

425 Haaland Dr.
Suite 103
Thousand Oaks, CA 91361

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Lung Cancer - NSCLC
Request Information
Mirati, 849-007

A Phase 2 Trial of MRTX849 in Combination with Pembrolizumab in Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation

Locations

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Lung Cancer (NSCLC)
Request Information
Mirati 849-012

A Randomized Phase 3 Study of MRTX849 versus Docetaxel in Patients with Previously Treated Non-Small Cell Lung Cancer with KRAS G12C Mutation.

Locations

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Lung Cancer (NSCLC)
Request Information
Momenta MOM-M281-006

Efficacy and Safety of M281 in Adults with Warm Autoimmune Hemolytic Anemia: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

Locations

900 S. Main St.
Suite 204
Corona, CA 92882

11480 Brookshire Ave.
Suite 309
Downey, CA 90241

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

3628 E. Imperial Hwy.
Suite 401
Lynwood, CA 90262

101 E. Beverly Blvd.
Suite 200
Montebello, CA 90640

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

1250 S. Sunset Ave.
Suite 101
West Covina, CA 91790

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted AIHA (Warm)
Request Information
Morphosys MOR208C204 (B-MIND)

A Phase II/III, Randomized, Multicenter Study of MOR00208 with Bendamustine versus Rituximab with Bendamustine in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R-R DLBCL) Who Are not Eligible for High-Dose Chemotherapy (HDC) and Autologous Stem-Cell Transplantation (ASCT) – B-MIND

Locations

1801 W Romneya Dr.
Suite 103
Anaheim, CA 92801

11480 Brookshire Ave.
Suite 309
Downey, CA 90241

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

1701 E. Cesar Chavez Ave.
Suite 535
Los Angeles, CA 90033

3628 E. Imperial Hwy.
Suite 401
Lynwood, CA 90262

101 E. Beverly Blvd.
Suite 200
Montebello, CA 90640

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

21605 Hawthorne Blvd.
Suite 200
Torrance, CA 90503

1250 S. Sunset Ave.
Suite 101
West Covina, CA 91790

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Non-Hodgkins Lymphoma (DLBCL)
Request Information
Napo Pharmaceuticals, NP303-102

A Phase 3 Multicenter, Randomized, Double-Blind Placebo-Controlled Trial Evaluating Crofelemer for the Prophylaxis of Diarrhea in Adult Patients with Solid Tumors Receiving Targeted-Cancer Therapies with or without Standard Chemotherapy Regimens.

Locations

900 S. Main St.
Suite 204
Corona, CA 92882

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

4646 Brockton Ave.
Suite 203
Riverside, CA 92506

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Solid Tumors (Supportive Care)
Request Information
NeoImmunoTech, NIT-119

A multicenter, open-label, single-arm Phase II study to evaluate anti-tumor efficacy and safety of NT-I7 (efineptakin alfa) in combination with atezolizumab in subjects with previously untreated, PD-L1- expressing, locally advanced or metastatic

Locations

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

1513 S. Grand Ave.
Suite 360
Los Angeles, CA 90015

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Lung Cancer (NSCLC)
Request Information
Novocure EF-24 (LUNAR)

LUNAR: Pivotal, Randomized, Open-Label Study of Tumor Treating Fields (TTFields) Concurrent with Standard of Care Therapies for Treatment of Stage 4 Non-Small Cell Lung Cancer (NSCLC) Following Platinum Failure

Locations

1801 W Romneya Dr.
Suite 103
Anaheim, CA 92801

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

3628 E. Imperial Hwy.
Suite 401
Lynwood, CA 90262

101 E. Beverly Blvd.
Suite 200
Montebello, CA 90640

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

1250 S. Sunset Ave.
Suite 101
West Covina, CA 91790

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Lung Cancer (NSCLC)
Request Information
NuCana NuTide121

A Phase III Open-Label, Multicenter, Randomized Study Comparing NUC-1031 Plus Cisplatin to Gemcitabine Plus Cisplatin in Patients with Previously Untreated Locally Advanced or Metastatic Biliary Tract Cancer

Locations

1801 W Romneya Dr.
Suite 103
Anaheim, CA 92801

900 S. Main St.
Suite 204
Corona, CA 92882

11480 Brookshire Ave.
Suite 309
Downey, CA 90241

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

3628 E. Imperial Hwy.
Suite 401
Lynwood, CA 90262

101 E. Beverly Blvd.
Suite 200
Montebello, CA 90640

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

1250 S. Sunset Ave.
Suite 101
West Covina, CA 91790

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Cholangiocarcinoma
Request Information
OnQuality OQL011B002

A Phase II Study to Evaluate the Safety and Efficacy of OQL011 on VEGFR Inhibitor-Associated Hand-Foot Skin Reaction in Cancer Patients

Locations

900 S. Main St.
Suite 204
Corona, CA 92882

11480 Brookshire Ave.
Suite 309
Downey, CA 90241

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

3628 E. Imperial Hwy.
Suite 401
Lynwood, CA 90262

101 E. Beverly Blvd.
Suite 200
Montebello, CA 90640

4500 Brockton Ave.
Suite 316
Riverside, CA 92501

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

1250 S. Sunset Ave.
Suite 101
West Covina, CA 91790

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Hand & Foot Skin Reaction
Request Information
Pfizer B8011011

A Phase 1b/2 Open-Label Umbrella Study of Sasanlimab Combined with Anti-Cancer Therapies Targeting Multiple Molecular Mechanisms in Participants with Non-Small Cell Lung Cancer (NSCLC)

Locations

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

1513 S. Grand Ave.
Suite 360
Los Angeles, CA 90015

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Lung Cancer - NSCLC
Request Information
Pfizer C3441037

A Phase 1, Open Label, Crossover Study to Establish Bioequivalence Between the Proposed Soft Gel Talazoparib Capsule Formulation and the Current Talazoparib Commercial Formulation and to Estimate the Food Effect on Pharmacokinetics of the Proposed Talazoparib Soft Gel Capsule Formulation in Participants with Advanced Solid Tumors.

Locations

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Solid Tumors
Request Information
Roche BO42161

A Phase III, Randomized, Open-Label, Active-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Crovalimab Versus Eculizumab in Adult and Adolescent Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated with Complement Inhibitors

Locations

11480 Brookshire Ave.
Suite 309
Downey, CA 90241

3300 E. South St.
Suite 304
Long Beach, CA 90805

1701 E. Cesar Chavez Ave.
Suite 535
Los Angeles, CA 90033

3628 E. Imperial Hwy.
Suite 401
Lynwood, CA 90262

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Paroxysmal Nocturnal Hemoglobinuria
Request Information
Roche BO42162

A Phase III, Randomized, Open-Label, Active-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Crovalimab Versus Eculizumab in Adult and Adolescent Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) not Previously Treated with Complement Inhibitors

Locations

11480 Brookshire Ave.
Suite 309
Downey, CA 90241

3300 E. South St.
Suite 304
Long Beach, CA 90805

1701 E. Cesar Chavez Ave.
Suite 535
Los Angeles, CA 90033

3628 E. Imperial Hwy.
Suite 401
Lynwood, CA 90262

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Paroxysmal Nocturnal Hemoglobinuria
Request Information
Sanofi Aventis ACT16525

Open-Label, Single-Arm Trial To Evaluate Antitumor Activity, Safety, And Pharmacokinetics Of SAR408701 Used In Combination With Ramucirumab In Metastatic, Non-Squamous, Non–Small-Cell Lung Cancer (NSQ NSCLC) Patients With CEACAM5-Positive Tumors, Previously Treated With Platinum-Based Chemotherapy And An Immune Checkpoint Inhibitor.

Locations

1513 S. Grand Ave.
Suite 360
Los Angeles, CA 90015

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Lung Cancer Cohort
Request Information
Seagen, SGN35-031

A Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Multicenter, Phase 3 Study of Brentuximab Vedotin or Placebo in Combination With Lenalidomide and Rituximab in Subjects with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

Locations

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

3628 E. Imperial Hwy.
Suite 401
Lynwood, CA 90262

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Non-Hodgkins Lymphoma (DLBCL)
Request Information
Pfizer, C366100

Phase 1/2a dose escalation and expansion study evaluating safety, tolerability, pharmacokinetic, pharmacodynamics and anti-tumor activity of pf-06873600 as a single agent and in combination with endocrine therapy

Locations

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Endocrine
Request Information
SecuraBio RECOMM

A Disease Registry Encompassing the Care of Patients with Multiple Myeloma on Panobinostat (RECOMM)

Locations

900 S. Main St.
Suite 204
Corona, CA 92882

11480 Brookshire Ave.
Suite 309
Downey, CA 90241

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

1701 E. Cesar Chavez Ave.
Suite 535
Los Angeles, CA 90033

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

1250 S. Sunset Ave.
Suite 101
West Covina, CA 91790

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Multiple Myeloma
Request Information
Sellas SLS17-201/MK3475-770

A Phase 1/2 Study of Galinpepimut-S in Combination with Pembrolizumab (MK-3475) in Patients with Selected Advanced Cancers

Locations

11480 Brookshire Ave.
Suite 309
Downey, CA 90241

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

1701 E. Cesar Chavez Ave.
Suite 535
Los Angeles, CA 90033

3628 E. Imperial Hwy.
Suite 401
Lynwood, CA 90262

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

1250 S. Sunset Ave.
Suite 101
West Covina, CA 91790

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Multiple tumors -starting with AML
Request Information
Sellas SLSG18-301

A Randomized, Open-Label Study of the Efficacy and Safety of Galinpepimut-S (GPS) Maintenance Monotherapy Compared to Investigator's Choice of Best Available Therapy in Subjects with Acute Myeloid Leukemia Who Have Achieved Complete Remission After Second-Line Salvage Therapy

Locations

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Acute Myelogenous Leukemia
Request Information
Shanghai Haihe SCC244-108

A Randomized, Open-Label Study of the Efficacy and Safety of Galinpepimut-S (GPS) Maintenance Monotherapy Compared to Investigator's Choice of Best Available Therapy in Subjects with Acute Myeloid Leukemia Who Have Achieved Complete Remission After Second-Line Salvage Therapy

Locations

900 S. Main St.
Suite 204
Corona, CA 92882

11480 Brookshire Ave.
Suite 309
Downey, CA 90241

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

1701 E. Cesar Chavez Ave.
Suite 535
Los Angeles, CA 90033

3628 E. Imperial Hwy.
Suite 401
Lynwood, CA 90262

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

1250 S. Sunset Ave.
Suite 101
West Covina, CA 91790

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Lung Cancer - NSCLC
Request Information
Spectrum SPI-BEL-107

An Open-label, Nonrandomized, Phase 1 Drug-Drug Interaction Study to Evaluate the Pharmacokinetics of Belinostat in Combination with Atazanavir in Patients with Advanced Relapsed/Refractory Solid Tumors or Hematological Malignancies

Locations

1801 W Romneya Dr.
Suite 103
Anaheim, CA 92801

11480 Brookshire Ave.
Suite 309
Downey, CA 90241

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

1701 E. Cesar Chavez Ave.
Suite 535
Los Angeles, CA 90033

3628 E. Imperial Hwy.
Suite 401
Lynwood, CA 90262

101 E. Beverly Blvd.
Suite 200
Montebello, CA 90640

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

1250 S. Sunset Ave.
Suite 101
West Covina, CA 91790

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Solid Tumors
Request Information
Sun Pharma CLR_15_03 PART C

A Two-Part Phase 1/2 Study to Determine Safety, Tolerability, Pharmacokinetics, and Activity of K0706, a Novel Tyrosine Kinase Inhibitor (TKI), in Healthy Subjects and in Subjects with Chronic Myeloid Leukemia (CML) or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Locations

1801 W Romneya Dr.
Suite 103
Anaheim, CA 92801

11480 Brookshire Ave.
Suite 309
Downey, CA 90241

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

1701 E. Cesar Chavez Ave.
Suite 535
Los Angeles, CA 90033

3628 E. Imperial Hwy.
Suite 401
Lynwood, CA 90262

101 E. Beverly Blvd.
Suite 200
Montebello, CA 90640

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

21605 Hawthorne Blvd.
Suite 200
Torrance, CA 90503

1250 S. Sunset Ave.
Suite 101
West Covina, CA 91790

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted CML / ALL
Request Information
Suzhou Zanrong (Zion) ZN-A-1041-101

A Phase 1 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ZN-A-1041 Enteric Capsules as a Single Agent or in Combination with Capecitabine Tablets in Patients with HER2-Positive Advanced Solid Tumors

Locations

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

1701 E. Cesar Chavez Ave.
Suite 535
Los Angeles, CA 90033

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Breast Cancer
Request Information
Viracta Therapeutics, VT3996-202

An Open-Label, Phase 2 Trial of Nanatinostat in Combination with Valganciclovir in Patients with Epstein-Barr Virus-Positive (EBV+)

Locations

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

3628 E. Imperial Hwy.
Suite 401
Lynwood, CA 90262

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL)
Request Information
Zhejiang Teruisi Pharma., TRS00303001

A Phase 3, Multicenter, Randomized and Double-Blind Study to Assess the Similarity in Efficacy and Safety between TRS003 and China-approved Bevacizumab Administered in Combination with Paclitaxel-Carboplatin in Subjects with Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC)

Locations

11480 Brookshire Ave.
Suite 309
Downey, CA 90241

1701 E. Cesar Chavez Ave.
Suite 535
Los Angeles, CA 90033

1510 S. Central Ave.
Suite 240
Glendale, CA 91204

3300 E. South St.
Suite 304
Long Beach, CA 90805

3628 E. Imperial Hwy.
Suite 401
Lynwood, CA 90262

999 N. Tustin Ave
Suite 212
Santa Ana, CA 92705

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted Lung Cancer (NSCLC)
Request Information
Zymeworks ZWI-ZW25-203

A Phase 2b, Open-Label, Single-Arm Study of ZW25 Monotherapy in Subjects with Advanced or Metastatic HER2-Amplified Biliary Tract Cancers

Locations

3300 E. South St.
Suite 304
Long Beach, CA 90805

8135 S. Painter Ave.
Suite 103
Whittier, CA 90602

Cancer Targeted CholangioCarcinoma & Gall Bladder Cancer
Request Information